AU2002230579A1 - Calcilytic compounds - Google Patents

Calcilytic compounds

Info

Publication number
AU2002230579A1
AU2002230579A1 AU2002230579A AU3057902A AU2002230579A1 AU 2002230579 A1 AU2002230579 A1 AU 2002230579A1 AU 2002230579 A AU2002230579 A AU 2002230579A AU 3057902 A AU3057902 A AU 3057902A AU 2002230579 A1 AU2002230579 A1 AU 2002230579A1
Authority
AU
Australia
Prior art keywords
calcilytic compounds
compounds
calcilytic
methods
novel calcilytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002230579A
Inventor
William M. Bryan
James F. Callahan
F. Huffman. William
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2002230579A1 publication Critical patent/AU2002230579A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Novel calcilytic compounds and methods of using them are provided.
AU2002230579A 2000-10-25 2001-10-25 Calcilytic compounds Abandoned AU2002230579A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24300700P 2000-10-25 2000-10-25
US60/243,007 2000-10-25
PCT/US2001/046233 WO2002034204A2 (en) 2000-10-25 2001-10-25 Calcilytic compounds

Publications (1)

Publication Number Publication Date
AU2002230579A1 true AU2002230579A1 (en) 2002-05-06

Family

ID=22916980

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002230579A Abandoned AU2002230579A1 (en) 2000-10-25 2001-10-25 Calcilytic compounds

Country Status (8)

Country Link
US (1) US20040014723A1 (en)
EP (1) EP1383511B1 (en)
JP (1) JP2004514659A (en)
AT (1) ATE343390T1 (en)
AU (1) AU2002230579A1 (en)
DE (1) DE60124148T2 (en)
ES (1) ES2273909T3 (en)
WO (1) WO2002034204A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR042132A1 (en) 2002-11-26 2005-06-08 Smithkline Beecham Corp COMPOUND OF 2- HYDROXI -3- (2- ARIL - 1, 1 - DIMETHYLETHYLAMINE) PROPOXIFENILO, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS AND USES IT TO PREPARE IT
ES2337576T3 (en) * 2003-04-23 2010-04-27 Japan Tobacco Inc. DECASR ANTAGONIST.
JPWO2004106280A1 (en) 2003-05-28 2006-07-20 日本たばこ産業株式会社 CaSR antagonist
RU2502730C2 (en) * 2008-06-05 2013-12-27 Асахи Касеи Фарма Корпорейшн Sulphonamide compounds and use thereof
WO2010113860A1 (en) * 2009-03-31 2010-10-07 第一三共株式会社 Biphenyl-cyclic amine compound
DE102011083595A1 (en) 2011-09-28 2013-03-28 Bayer Pharma AG Inhibition of the effect of interleukin 1 beta for the treatment of endometriosis
GB201217330D0 (en) 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789397A (en) * 1991-01-08 1998-08-04 Bone Care International, Inc. Methods for preparation and use of 1A,24(S)-dihydroxy vitamin D2
DE4141928A1 (en) * 1991-12-19 1993-06-24 Boehringer Mannheim Gmbh NEW PHOSPHON AMBER ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
WO1997037967A1 (en) * 1996-04-09 1997-10-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
UY24949A1 (en) * 1997-04-08 2001-04-30 Smithkline Beecham Corp CALCILITE COMPOUNDS
AR014975A1 (en) * 1998-04-08 2001-04-11 Nps Pharma Inc CALCILITICAL COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM, AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
PE20000415A1 (en) * 1998-04-08 2000-05-21 Smithkline Beecham Corp CALCILITIC COMPOUNDS
PE20001456A1 (en) * 1999-02-02 2001-01-28 Smithkline Beecham Corp CALCIOLYTIC COMPOUNDS
AR030684A1 (en) * 2000-01-24 2003-09-03 Smithkline Beecham Corp CALCILITICAL COMPOUNDS, USE OF SUCH COMPOUNDS IN THE MANUFACTURE OF MEDICINES, AND USEFUL INTERMEDIARIES IN THE PREPARATION OF SUCH COMPOUNDS

Also Published As

Publication number Publication date
ATE343390T1 (en) 2006-11-15
EP1383511A2 (en) 2004-01-28
DE60124148D1 (en) 2006-12-07
WO2002034204A3 (en) 2003-11-06
US20040014723A1 (en) 2004-01-22
EP1383511B1 (en) 2006-10-25
WO2002034204A8 (en) 2003-12-24
EP1383511A4 (en) 2005-05-18
ES2273909T3 (en) 2007-05-16
JP2004514659A (en) 2004-05-20
DE60124148T2 (en) 2007-09-06
WO2002034204A2 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
IL147803A0 (en) 28-epirapalogs
AU2001239725A1 (en) Antibacterial agents
AU2003299585A1 (en) Water-soluble products and methods of making and using the same
WO2003035617A3 (en) Derivatives of uk-2a
AU2002367580A1 (en) Tissue-engineered organs
MY133969A (en) Indoloquinazolinones
AU2003290592A1 (en) Antitumor benzoylsulfonamides
HK1045990A1 (en) Novel derivatives and analogues of galanthamin.
MXPA01010403A (en) Osteopontin-derived chemotactic and inhibitory agents and uses therefor.
AP2001002220A0 (en) Calcilytic compounds.
AP2002002547A0 (en) Calcilytic compounds.
AU2002230579A1 (en) Calcilytic compounds
MY133881A (en) "calcilytic compounds"
MXPA02011558A (en) Novel mmp 2 mmp 9 inhibitors.
AU2002358179A1 (en) New rennets
WO2002038106A3 (en) Calcilytic compounds
TW200510276A (en) Calcilytic compounds
AU2002356615A1 (en) Novel utilization of cyclopentabenzofurans
AU2002258437A1 (en) Peptide deformylase inhibitors
AU2001278773A1 (en) Novel pla1
AUPQ599500A0 (en) Novel peptides, modulatory agents therefor and methods of using them
AU2001267699A1 (en) Testing of leather
AU2002322035A1 (en) Peptide deformylase inhibitors
AU2001233715A1 (en) Dermo- and gastro-specific sphingolipid activator
AU2001287673A1 (en) Novel trioxepan compounds